{"id":209509,"date":"2025-03-22T14:04:42","date_gmt":"2025-03-22T19:04:42","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/03\/automated-insulin-delivery-improves-glycemic-control-of-type-2-diabetes-in-randomized-trial"},"modified":"2025-03-22T14:04:42","modified_gmt":"2025-03-22T19:04:42","slug":"automated-insulin-delivery-improves-glycemic-control-of-type-2-diabetes-in-randomized-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/03\/automated-insulin-delivery-improves-glycemic-control-of-type-2-diabetes-in-randomized-trial","title":{"rendered":"Automated insulin delivery improves glycemic control of type 2 diabetes in randomized trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/automated-insulin-delivery-improves-glycemic-control-of-type-2-diabetes-in-randomized-trial.jpg\"><\/a><\/p>\n<p>Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly lowered glycated hemoglobin (HbA1c) levels and improved glucose control compared to standard insulin therapy with continuous glucose monitoring (CGM).<\/p>\n<p>AID therapy resulted in a mean HbA1c reduction of 0.9 percentage points over 13 weeks, while the control group experienced a 0.3 percentage point reduction.<\/p>\n<p>Automated <a href=\"https:\/\/medicalxpress.com\/tags\/insulin+delivery\/\" rel=\"tag\" class=\"\">insulin delivery<\/a> systems have demonstrated benefits for patients with type 1 diabetes, yet their efficacy and safety for individuals with type 2 diabetes remain less established. Prior studies have either lacked randomized controlled designs or involved limited sample sizes, creating a gap in clinical understanding.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly lowered glycated hemoglobin (HbA1c) levels and improved glucose control compared to standard insulin therapy with continuous glucose monitoring (CGM). AID therapy resulted in a mean HbA1c reduction of [\u2026]<\/p>\n","protected":false},"author":732,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,6],"tags":[],"class_list":["post-209509","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/209509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/732"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=209509"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/209509\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=209509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=209509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=209509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}